Evidence map›Paper›PMID 31139573›Full record

ArticleFrontiers in oncology2019

The Combination of Particle Irradiation With the Hedgehog Inhibitor GANT61 Differently Modulates the Radiosensitivity and Migration of Cancer Cells Compared to X-Ray Irradiation.

Katrien Konings, Charlot Vandevoorde, Niels Belmans, Randy Vermeesen, Bjorn Baselet, Merel Van Walleghem, Ann Janssen, Sofie Isebaert, Sarah Baatout, Karin Haustermans and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Basic and translational research on carbon-ion radiobiology.American journal of cancer research · 2023
    Review
  6. Review
  7. Article
  8. Molecules (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Article
  11. First reported case of concurrent sonidegib and radiotherapy for recurrent, advanced basal cell carcinoma.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2021
    Article
  12. Article
  13. The 20th Gray lecture 2019: health and heavy ions.The British journal of radiology · 2020
    Review
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Katrien KoningsRadiobiology Unit, Belgian Nuclear Research Center (SCK•CEN), Institute for Environment, Health and Safety, Mol, Belgium.
Charlot VandevoordeRadiation Biophysics Division, NRF iThemba LABS, Faure, South Africa.
Niels BelmansRadiobiology Unit, Belgian Nuclear Research Center (SCK•CEN), Institute for Environment, Health and Safety, Mol, Belgium.
Randy VermeesenRadiobiology Unit, Belgian Nuclear Research Center (SCK•CEN), Institute for Environment, Health and Safety, Mol, Belgium.
Bjorn BaseletRadiobiology Unit, Belgian Nuclear Research Center (SCK•CEN), Institute for Environment, Health and Safety, Mol, Belgium.
Merel Van WalleghemRadiobiology Unit, Belgian Nuclear Research Center (SCK•CEN), Institute for Environment, Health and Safety, Mol, Belgium.
Ann JanssenRadiobiology Unit, Belgian Nuclear Research Center (SCK•CEN), Institute for Environment, Health and Safety, Mol, Belgium.
Sofie IsebaertLaboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.
Sarah BaatoutRadiobiology Unit, Belgian Nuclear Research Center (SCK•CEN), Institute for Environment, Health and Safety, Mol, Belgium.
Karin HaustermansLaboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.
Marjan MoreelsRadiobiology Unit, Belgian Nuclear Research Center (SCK•CEN), Institute for Environment, Health and Safety, Mol, Belgium.
Belgian Nuclear Research Centre · BEKU Leuven · BEiThemba Laboratory · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the advantages of charged particles compared to conventional radiotherapy, a vast increase is noted in the use of particle therapy in the clinic. These advantages include an improved dose deposition and increased biological effectiveness. Metastasis is still an important cause of mortality in cancer patients and evidence has shown that conventional radiotherapy can increase the formation of metastasizing cells. An important pathway involved in the process of metastasis is the Hedgehog (Hh) signaling pathway. Recent studies have demonstrated that activation of the Hh pathway, in response to X-rays, can lead to radioresistance and increased migratory, and invasive capabilities of cancer cells. Here, we investigated the effect of X-rays, protons, and carbon ions on cell survival, migration, and Hh pathway gene expression in prostate cancer (PC3) and medulloblastoma (DAOY) cell lines. In addition, the potential modulation of cell survival and migration by the Hh pathway inhibitor GANT61 was investigated. We found that in both cell lines, carbon ions were more effective in decreasing cell survival and migration as well as inducing more significant alterations in the Hh pathway genes compared to X-rays or protons. In addition, we show here for the first time that the Hh inhibitor GANT61 is able to sensitize DAOY medulloblastoma cells to particle radiation (proton and carbon ion) but not to conventional X-rays. This important finding demonstrates that the results of combination treatment strategies with X-ray radiotherapy cannot be automatically extrapolated to particle therapy and should be investigated separately. In conclusion, combining GANT61 with particle radiation could offer a benefit for specific cancer types with regard to cancer cell survival.

Indexed as

carbon ionGANT61gene expressionHedgehog pathwaymigrationparticle therapyprotonradiosensitization

Identifiers

PMID31139573
PMCPMC6527843
OpenAlexW2945067601

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.